Dr. Anari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Philadelphia, PA 19111Phone+1 215-728-2500Fax+1 215-728-3639
Clinical Expertise
- Medical education
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2013 - 2016
Rutgers Robert Wood Johnson Medical SchoolClass of 2013
Certifications & Licensure
PA State Medical License 2013 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 35 citationsDual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch ...Arthur Winer, Pooja Ghatalia, Nicole Bubes, Fern Anari, Asya Varshavsky
The Oncologist. 2019-11-01 - 15 citationsComparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma.Kevin K Zarrabi, Elizabeth Handorf, Benjamin Miron, Matthew R Zibelman, Fern Anari
The Oncologist. 2023-02-08 - 53 citationsDefects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerBenjamin Miron, Jean H. Hoffman-Censits, Fern Anari, John O'Neill, Daniel M. Geynisman
European Urology Oncology. 2020-03-10
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
